Skip to content

Evidence Hub

Blog
Feb 27, 2020

Aetion, Dr. Scott Gottlieb, biopharma leaders’ discussions at JPM 2020: It’s time to “knock on an open door” to further RWE standards and acceptance

This January, in the whirlwind week of the 36th Annual J.P. Morgan Healthcare Conference ...
Start Reading
Blog
Feb 20, 2020

How to amplify RWE clarity and reproducibility with data visualizations: Q&A with Dr. Shirley Wang of the REPEAT initiative

While analyses of non-randomized health care databases—insurance claims, electronic ...
Start Reading
Blog
Feb 20, 2020

Artificial Intelligence in Health Care - GAO Report

Benefits and Challenges of Machine Learning in Drug Development The adoption of ...
Start Reading
Blog
Feb 11, 2020

Why diverse data teams lead to bigger wins, and other perspectives from retail tech: A Q&A with Stitch Fix CTO, Cathy Polinsky

Cathy Polinsky’s deep love of programming, problem-solving, and perfecting client ...
Start Reading
Blog
Feb 6, 2020

How emerging technologies will ensure increasing availability of RWD

The potential of real-world data (RWD) to transform clinical trials is drawing attention ...
Start Reading
Blog
Jan 30, 2020

Contextual considerations in RWE generation and use

There’s a lot of buzz around the potential impact of real-world evidence (RWE) in health ...
Start Reading
Blog
Jan 23, 2020

The shift from health technology assessment to management: What is RWE’s role?

As innovation in health care advances—and the associated costs escalate—payers are ...
Start Reading
Blog
Jan 15, 2020

RWE use by HTAs: How has it evolved, and where is it headed next? Q&A with Dr. Jens Grueger

Health technology assessment (HTA) agencies are increasingly turning to real-world ...
Start Reading
Blog
Jan 9, 2020

RWE and the value equation: U.S. health care purchaser perspectives on payment model evolution and the role of RWE

Much discussion surrounds rising drug prices—and the numerous parties affected. ...
Start Reading
Blog
Dec 20, 2019

Let’s talk about value: How biopharma can maximize utility of RWE in value discussions

With the drug pricing pressures mounting on a global scale, there is a clear and imminent ...
Start Reading
Blog
Dec 14, 2019

Ask our experts: Working with real world data sets: What types of questions can your data answer?

The promise of real-world evidence (RWE) comes with a steep learning curve. As regulators ...
Start Reading
Blog
Dec 10, 2019

Managing the Risks from AI Algorithms

In the webinar organized by Replica Analytics in November 2019 entitled "Managing the ...
Start Reading
Blog
Dec 6, 2019

Advancing cancer care with real-world data: Next steps for collaborators

In oncology, over 90 percent of patient treatment experiences occur outside of clinical ...
Start Reading
Blog
Nov 23, 2019

Evidence at the Apex: Five learnings from the first annual Aetion Summit

Last month, the inaugural Aetion Summit in New York City brought together some of the ...
Start Reading
Blog
Nov 21, 2019

Learnings from three FDA decisions on ECA submissions in oncology

The publication of the Framework for FDA’s Real-World Evidence Program nearly a year ago ...
Start Reading
Blog
Nov 15, 2019

Spotlight on trust and transparency at ISPOR Europe 2019

The digital age has transformed the amount and quality of data available and given rise ...
Start Reading
Blog
Nov 8, 2019

Bold moves in RWE — from FDA, industry, and tech at HLTH 2019

Two weeks ago, researchers at NYU published new findings on how objects move against a ...
Start Reading
Blog
Oct 30, 2019

RWE advances amidst “data tsunami”: Takeaways from FOCR 8th Annual Blueprint for Breakthrough Forum

Breakthroughs in data extraction and analysis coupled with federal infrastructure ...
Start Reading
Blog
Oct 25, 2019

FDA’s Technology Modernization Action Plan: Three ways to prepare for the coming RWE infrastructure

The U.S. Food and Drug Administration (FDA) recognizes that common standards and a shared ...
Start Reading
Blog
Oct 12, 2019

The case for real-world evidence in health technology assessment

New drugs are launched based on data from randomized controlled trials (RCTs), the gold ...
Start Reading
Blog
Oct 4, 2019

On FHIR: How “Fast Healthcare Interoperability Resources” will improve real-world data quality

In 2009, health care data entered the digital age with the HITECH Act and the ...
Start Reading
Blog
Sep 27, 2019

Everyone in the pool: How diverse stakeholders speed RWE adoption

A recent issue of Clinical Pharmacology & Therapeutics focused entirely on real-world ...
Start Reading
Blog
Sep 20, 2019

Takeaways from the 35th ICPE

At the end of August, pharmacoepidemiology enthusiasts from across the globe gathered in ...
Start Reading
Blog
Sep 12, 2019

What can electronic health records tell us—and how? Q&A with Andrew Bate, Ph.D.

As pharma manufacturers and regulatory agencies increase the role of real-world data ...
Start Reading